2021 Spring Virtual PME Symposia

Round out your educational experience by attending Professional Medical Education/Product Theater symposia focused on novel therapies. These non-certified activities are planned solely by the sponsoring organizations/companies.

FRIDAY, APRIL 16, 2021 · 7:00 – 8:00 AM Pacific Time

PME Symposium
A Treatment Option for Heart Failure Patients With Reduced Ejection Fraction

Presenter: Wilson S. Colucci, MD, FACC, FAHA

Sponsored by Merck Sharp and Dohme Corp.

Program Description:

The objective of this presentation is to review safety and efficacy of a treatment option for patients with symptomatic chronic HF with EF <45%.

FRIDAY, APRIL 16, 2021 · 12:00 – 1:00 PM Pacific Time

PME Symposium
The Continuum of Heart Failure

Presenter: Jonathan D. Rich, MD, FACC, FHFSA

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.

Program Description:

The objective of this program is to discuss the pathophysiology, disease burden, and management of heart failure (HF). The program will present data on HF prevalence and health outcomes, review the implications of type 2 diabetes as a common comorbidity, and provide guidance on diagnosing HF. It will conclude with a brief overview of current treatment options for HF.

FRIDAY, APRIL 16, 2021 · 6:45 – 7:45 PM Pacific Time

PME Symposium
Jardiance® (empagliflozin) tablets: A Review of Multiple Clinical Trials and Approved Indications

Presenter: Matthew Budoff, MD

Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc and Lilly USA, LLC.

Program Description:

This program will review multiple clinical trials and approved indications for JARDIANCE. The presentation will cover efficacy and safety data, as well as the dosing information for JARDIANCE. Attendees will also have the opportunity to ask the faculty questions about the data presented.